Analytical Data
-
Gene name
C1orf109
- Application
-
Alternative Names
C1orf109; Uncharacterized Protein C1orf109
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NX04
-
Expression Region
1-203aa
-
AA Sequence
MTQDRPLLAV QEALKKCFPV VEEQQGLWQS ALRDCQPLLS SLSNLAEQLQ AAQNLRFEDV PALRAFPDLK ERLRRKQLVA GDIVLDKLGE RLAILLKVRD MVSSHVERVF QIYEQHADTV GIDAVLQPSA VSPSVADMLE WLQDIERHYR KSYLKRKYLL SSIQWGDLAN IQALPKAWDR ISKDEHQDLV QDILLNVSFF LEE
-
Molecular Weight
49.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf109, also known as "Chromosome 1 open reading frame 109," is a relatively uncharacterized protein that has garnered attention in recent years due to its potential roles in various biological processes and diseases. Emerging evidence suggests that C1orf109 may be involved in cellular signaling pathways, impacting processes such as cell proliferation, apoptosis, and immune responses. Its expression patterns in different tissues and during various developmental stages indicate a possible role in human health and disease, including cancer and genetic disorders. The recombinant protein of C1orf109 is being explored for its utility in understanding its functional properties, interactions with other proteins, and potential implications in therapeutic applications. Production of C1orf109 as a recombinant protein allows researchers to investigate its structure-function relationships and facilitate the discovery of its biological roles, presenting opportunities for novel biomarker or therapeutic development. Overall, the study of C1orf109 represents a promising frontier in molecular biology and medicine, with the potential to unravel new insights into disease mechanisms and contribute to the development of innovative treatments.
